Cargando…

Circulating Tumour Cell Biomarkers in Head and Neck Cancer: Current Progress and Future Prospects

Head and neck cancer (HNC) continues to carry a significant burden of disease both for patients and health services. Facilitating biomarker-led treatment decisions is critical to improve outcomes in this group and deliver therapy tailored to the individual tumour biological profile. One solution to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Payne, Karl, Brooks, Jill, Spruce, Rachel, Batis, Nikolaos, Taylor, Graham, Nankivell, Paul, Mehanna, Hisham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721520/ https://www.ncbi.nlm.nih.gov/pubmed/31387228 http://dx.doi.org/10.3390/cancers11081115

Ejemplares similares

Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma
por: Payne, Karl, et al.
Publicado: (2022)

Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Payne, Karl, et al.
Publicado: (2020)

Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
por: Payne, Karl, et al.
Publicado: (2023)

Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery
por: Payne, Karl, et al.
Publicado: (2021)

Ultra-Low DNA Input into Whole Genome Methylation Assays and Detection of Oncogenic Methylation and Copy Number Variants in Circulating Tumour DNA
por: Whalley, Celina, et al.
Publicado: (2021)

Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation()
por: Batis, Nikolaos, et al.
Publicado: (2021)

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
por: Bryant, Jennifer, et al.
Publicado: (2019)

Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
por: Mehanna, Hisham
Publicado: (2020)

Circulating Tumour Cells (CTC), Head and Neck Cancer and Radiotherapy; Future Perspectives
por: Perumal, Vanathi, et al.
Publicado: (2019)

Clinicians' Views of Patient-initiated Follow-up in Head and Neck Cancer: a Qualitative Study to Inform the PETNECK2 Trial
por: Lorenc, A., et al.
Publicado: (2022)

The Clinical Utility of Cell-Free DNA Measurement in Differentiated Thyroid Cancer: A Systematic Review
por: Fussey, Jonathan M., et al.
Publicado: (2018)

Exploring the views of patients' and their family about patient‐initiated follow‐up in head and neck cancer: A mixed methods study
por: Lorenc, Ava, et al.
Publicado: (2022)

Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study
por: Mehanna, Hisham, et al.
Publicado: (2019)

Feasibility of recruitment to an oral dysplasia trial in the United Kingdom
por: Nankivell, Paul, et al.
Publicado: (2012)

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
por: Vreugdenhil, M., et al.
Publicado: (2021)

Adapting Head and Neck Cancer Management in the Time of COVID-19
por: Mehanna, Hisham, et al.
Publicado: (2020)

Association between loss of Y chromosome and poor prognosis in male head and neck squamous cell carcinoma
por: Hollows, Robert, et al.
Publicado: (2018)

Refeeding syndrome – awareness, prevention and management
por: Mehanna, Hisham, et al.
Publicado: (2009)

Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1
por: Lai, Sook Ling, et al.
Publicado: (2019)

Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol
por: Kong, Anthony, et al.
Publicado: (2020)

Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient
por: Bresadola, Luisa, et al.
Publicado: (2021)

Immunotherapy of Head and Neck Cancer: Current and Future Considerations
por: Rapidis, Alexander D., et al.
Publicado: (2009)

Barriers to recruitment for surgical trials in head and neck oncology: a survey of trial investigators
por: Kaur, Geetinder, et al.
Publicado: (2013)

Impact of label-free technologies in head and neck cancer circulating tumour cells
por: Kulasinghe, Arutha, et al.
Publicado: (2016)

Short term ex-vivo expansion of circulating head and neck tumour cells
por: Kulasinghe, Arutha, et al.
Publicado: (2016)

Enrichment of circulating head and neck tumour cells using spiral microfluidic technology
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

PD-L1 expressing circulating tumour cells in head and neck cancers
por: Kulasinghe, Arutha, et al.
Publicado: (2017)

Application of circulating tumour cells to predict response to treatment in head and neck cancer
por: Zhang, Xi, et al.
Publicado: (2022)

Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis
por: Henson, Christina E., et al.
Publicado: (2023)

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma
por: Huang, Xiaomin, et al.
Publicado: (2023)

Revised Modelling of the Addition of Synchronous Chemotherapy to Radiotherapy in Squamous Cell Carcinoma of the Head and Neck—A Low α/β?
por: Best, James, et al.
Publicado: (2018)

Early detection in head and neck cancer – current state and future perspectives
por: Gerstner, Andreas O. H.
Publicado: (2010)

Oncolytic virotherapy for head and neck cancer: current research and future developments
por: Malhotra, Akshiv, et al.
Publicado: (2015)

Electrochemotherapy in the Treatment of Head and Neck Cancer: Current Conditions and Future Directions
por: Enokida, Tomohiro, et al.
Publicado: (2021)

Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges
por: Kong, Lingyi, et al.
Publicado: (2021)

In vitro models for head and neck cancer: Current status and future perspective
por: Moya-Garcia, Christian R., et al.
Publicado: (2022)

A systematic review of the effectiveness of patient‐initiated follow‐up after cancer
por: Dretzke, Janine, et al.
Publicado: (2023)

Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines
por: Mehanna, H, et al.
Publicado: (2016)

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies
por: Mehanna, Hisham, et al.
Publicado: (2020)

Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma
por: Winter, Stuart C, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_65u2kigcphouo9r3d95c79cebd